218 related articles for article (PubMed ID: 15845893)
1. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
Wada T; Toma T; Okamoto H; Kasahara Y; Koizumi S; Agematsu K; Kimura H; Shimada A; Hayashi Y; Kato M; Yachie A
Blood; 2005 Sep; 106(6):2099-101. PubMed ID: 15845893
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.
Alsmadi O; Al-Ghonaium A; Al-Muhsen S; Arnaout R; Al-Dhekri H; Al-Saud B; Al-Kayal F; Al-Saud H; Al-Mousa H
BMC Med Genet; 2009 Nov; 10():116. PubMed ID: 19912631
[TBL] [Abstract][Full Text] [Related]
3. Omenn syndrome--review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan.
Kato M; Kimura H; Seki M; Shimada A; Hayashi Y; Morio T; Kumaki S; Ishida Y; Kamachi Y; Yachie A
Allergol Int; 2006 Jun; 55(2):115-9. PubMed ID: 17075247
[TBL] [Abstract][Full Text] [Related]
4. Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency.
Kumaki S; Villa A; Asada H; Kawai S; Ohashi Y; Takahashi M; Hakozaki I; Nitanai E; Minegishi M; Tsuchiya S
Blood; 2001 Sep; 98(5):1464-8. PubMed ID: 11520796
[TBL] [Abstract][Full Text] [Related]
5. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome.
Corneo B; Moshous D; Güngör T; Wulffraat N; Philippet P; Le Deist FL; Fischer A; de Villartay JP
Blood; 2001 May; 97(9):2772-6. PubMed ID: 11313270
[TBL] [Abstract][Full Text] [Related]
6. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.
Bai X; Liu J; Zhang Z; Liu C; Zhang Y; Tang W; Dai R; Wu J; Tang X; Zhang Y; Ding Y; Jiang L; Zhao X
Immunol Res; 2016 Apr; 64(2):497-507. PubMed ID: 26476733
[TBL] [Abstract][Full Text] [Related]
7. Three faces of recombination activating gene 1 (RAG1) mutations.
Patiroglu T; Akar HH; Van Der Burg M
Acta Microbiol Immunol Hung; 2015 Dec; 62(4):393-401. PubMed ID: 26689875
[TBL] [Abstract][Full Text] [Related]
8. [Clinical phenotype and gene diagnostic analysis of Omenn syndrome].
Wang YQ; Cui YX; Feng J
Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):64-8. PubMed ID: 23527934
[TBL] [Abstract][Full Text] [Related]
9. [Omenn Syndrome and DNA recombination defects].
Yachie A
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):179-189. PubMed ID: 28747605
[TBL] [Abstract][Full Text] [Related]
10. Compound heterozygous mutation of Rag1 leading to Omenn syndrome.
Matthews AG; Briggs CE; Yamanaka K; Small TN; Mooster JL; Bonilla FA; Oettinger MA; Butte MJ
PLoS One; 2015; 10(4):e0121489. PubMed ID: 25849362
[TBL] [Abstract][Full Text] [Related]
11. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
[TBL] [Abstract][Full Text] [Related]
12. RAG1 reversion mosaicism in a patient with Omenn syndrome.
Crestani E; Choo S; Frugoni F; Lee YN; Richards S; Smart J; Notarangelo LD
J Clin Immunol; 2014 Jul; 34(5):551-4. PubMed ID: 24817258
[TBL] [Abstract][Full Text] [Related]
13. Omenn syndrome does not live by V(D)J recombination alone.
Marrella V; Maina V; Villa A
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):525-31. PubMed ID: 22001740
[TBL] [Abstract][Full Text] [Related]
14. Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.
Meshaal S; El Hawary R; Elsharkawy M; Mousa RK; Farid RJ; Abd Elaziz D; Alkady R; Galal N; Massaad MJ; Boutros J; Elmarsafy A
Clin Immunol; 2015 Jun; 158(2):167-73. PubMed ID: 25869295
[TBL] [Abstract][Full Text] [Related]
15. Analysis of mutations and recombination activity in RAG-deficient patients.
Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
[TBL] [Abstract][Full Text] [Related]
16. A newly found homozygous mutation in recombination activating gene 1 in a patient with leaky severe combined immunodeficiency disorder.
Salari F; Zaremehrjardi F; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Seif F; Movahedi M; Nabavi M
Mol Biol Rep; 2019 Dec; 46(6):6571-6575. PubMed ID: 31520268
[TBL] [Abstract][Full Text] [Related]
17. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
[TBL] [Abstract][Full Text] [Related]
18. Omenn syndrome: a disorder of Rag1 and Rag2 genes.
Villa A; Santagata S; Bozzi F; Imberti L; Notarangelo LD
J Clin Immunol; 1999 Mar; 19(2):87-97. PubMed ID: 10226883
[TBL] [Abstract][Full Text] [Related]
19. Partial V(D)J recombination activity leads to Omenn syndrome.
Villa A; Santagata S; Bozzi F; Giliani S; Frattini A; Imberti L; Gatta LB; Ochs HD; Schwarz K; Notarangelo LD; Vezzoni P; Spanopoulou E
Cell; 1998 May; 93(5):885-96. PubMed ID: 9630231
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics of human recombination activating gene 1 mutations in 8 immunodeficiency patients with diverse phenotypes].
Yu G; Wang WJ; Liu DR; Tao ZF; Hui XY; Hou J; Sun JQ; Wang XC
Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):186-191. PubMed ID: 29518828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
